John Gillen
CEO & Director
For the past two decades John Gillen has dedicated his life to exploring the latest NAD+ (Nicotinamide Adenine Dinucleotide) therapies, delivering cutting-edge treatments to the UK and across Europe.
Learn MoreMeet the team behind our company's success! Our team consists of highly skilled professionals who are passionate about delivering exceptional results. We have diverse backgrounds and expertise in various fields, which allows us to approach problems from different perspectives.
The driving force behind our company's vision and mission
Our team of GPs and Nurses are dedicated to providing compassionate, patient-centered care.
Team Members
Our team of highly skilled therapists are committed to providing a safe and supportive environment for clients to explore their emotions and work through challenges
Discover the ways in which psychedelic therapy can help in treating depression and anxiety. Read more
While traditional talk therapy can be effective for many people, there is growing interest in exploring alternative forms of therapy that involve the use of mind-altering substances. Two such substances that are currently being explored for their therapeutic potential are MDMA and Ketamine. Read more
Discover the science behind ketamine and its use in psychotherapy. Explore how this emerging field is changing mental health treatment Read more